chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was given on 2/27/23- vaccine use by date was 2/12/23.  No harm, no reports of negative side effects.  Contacted Moderna and given the following information: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 27, 2023 from lot number 015B22A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration"
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was given on 2/27/23- vaccine use by date was 2/12/23.  No harm, no reports of negative side effects.  Contacted Moderna and given the following information: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 27, 2023 from lot number 015B22A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration"
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Computerised tomogram abdomen abnormal, Condition aggravated
Clinical narrative: Discharge Provider: DO Primary Care Provider, MD Admission Date: 3/4/2023 Discharge Date: 3/6/2023  PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 virus infection [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 6-year-old male who presented to the ER on 03/04/2023 with chief complaint of weakness.  At home patient was having increased weakness with inability to get off the toilet by himself.  He was helped back to bed however continued to have difficulty ambulating and was brought to the ER by EMS. In the emergency department he was positive for COVID-19.  Chest x-ray is negative.  CT scan of the abdomen done in the emergency department is consistent with constipation.  He was admitted to the hospitalist service for further management of generalized weakness and COVID-19.  He was started on remdesivir and completed 2 doses PT and OT were consulted during hospitalization who recommend outpatient therapy services.  The patient remained on room air throughout hospitalization.  On day of discharge patient states that he has been feeling well and agrees with plan to discharge home with additional outpatient resources.  All questions and concerns were addressed to patient's satisfaction and he was discharged in stable condition.
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Constipation, Gait disturbance, Mobility decreased, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: DO Primary Care Provider, MD Admission Date: 3/4/2023 Discharge Date: 3/6/2023  PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 virus infection [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 6-year-old male who presented to the ER on 03/04/2023 with chief complaint of weakness.  At home patient was having increased weakness with inability to get off the toilet by himself.  He was helped back to bed however continued to have difficulty ambulating and was brought to the ER by EMS. In the emergency department he was positive for COVID-19.  Chest x-ray is negative.  CT scan of the abdomen done in the emergency department is consistent with constipation.  He was admitted to the hospitalist service for further management of generalized weakness and COVID-19.  He was started on remdesivir and completed 2 doses PT and OT were consulted during hospitalization who recommend outpatient therapy services.  The patient remained on room air throughout hospitalization.  On day of discharge patient states that he has been feeling well and agrees with plan to discharge home with additional outpatient resources.  All questions and concerns were addressed to patient's satisfaction and he was discharged in stable condition.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Dyspnoea, Lung disorder, Pain in extremity, Renal cyst
Clinical narrative: After the vaccine I only had a sore arm, months later I went to my normal appointment to get my allergy shots. She was told she cant get her allergy shots because she wasn't breathing well, she was breathing below her breathing rate. they told her to see her primary care, because she needs to get her lungs taken a look at. She got a lung X-ray, they found a spot on her lungs that could  be ammonia and she needs a CT scan. They also, found a little on the inside of her lungs. they also found a cists on her kidney but thankfully wasn't cancer.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was given on 2/14/23- vaccine use by date was 2/12/23.  No harm, no reports of negative side effects.  Contacted Moderna and given the following information: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2023 from lot number 015B22A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration"
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: patient came in to receive their 4th dose which would be the Pfizer bivalent booster.  I MISTAKENLY gave them the new COMIRNATY (Pfizer) monovalent dose.  Upon realization that evening, I called patient to follow up and let them know of the error.  I let them know the guidelines that they do not need to restart the series and advised them to return in 2 months for the bivalent booster.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was given on 2/27/23- vaccine use by date was 2/12/23.  No harm, no reports of negative side effects.  Contacted Moderna and given the following information: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 27, 2023 from lot number 015B22A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration"
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthma, Condition aggravated, Cough, Fatigue, Human metapneumovirus test positive
Clinical narrative: He had fatigue, cough, and sore throat. We took him to urgent care, and they prescribed dexamethasone. He continued to get worse, so we took him to the emergency room, and he was hospitalized overnight because his asthma was flared up and they had to watch over him. They gave him prednisone and azithromycin.
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Viral test positive
Clinical narrative: He had fatigue, cough, and sore throat. We took him to urgent care, and they prescribed dexamethasone. He continued to get worse, so we took him to the emergency room, and he was hospitalized overnight because his asthma was flared up and they had to watch over him. They gave him prednisone and azithromycin.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Blood creatinine increased, COVID-19, Fatigue
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/3/2023 Discharge Date: Mar 4, 2023  PRESENTING PROBLEM: Acute kidney injury [N17.9] COVID-19 [U07.1]   HOSPITAL COURSE: Pt. is a 78 year old female with PMH of HTN, DM2, and mild dementia. Pt. reportedly has had generalized weakness and fatigue since 2/24/23. She was tested on 2/28/23 for COVID and found to be positive. Since then the patient has had worsening generalized weakness and fatigue for which she presented to the ED. Vitals have been stable on room air. Labs found to have a mild elevated creatinine and she was admitted to the hospital. Pt. reported poor oral intake and it was felt her AKI was pre-renal. She was given IVF over night and her creatinine improved back to baseline. Pt.'s generalized weakness improved with hydration. PT/OT recommended home with assist with home PT/OT. Pt. will follow up with her PCP outpatient. She is discharging in improved and stable condition.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hypophagia, Laboratory test abnormal, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/3/2023 Discharge Date: Mar 4, 2023  PRESENTING PROBLEM: Acute kidney injury [N17.9] COVID-19 [U07.1]   HOSPITAL COURSE: Pt. is a 78 year old female with PMH of HTN, DM2, and mild dementia. Pt. reportedly has had generalized weakness and fatigue since 2/24/23. She was tested on 2/28/23 for COVID and found to be positive. Since then the patient has had worsening generalized weakness and fatigue for which she presented to the ED. Vitals have been stable on room air. Labs found to have a mild elevated creatinine and she was admitted to the hospital. Pt. reported poor oral intake and it was felt her AKI was pre-renal. She was given IVF over night and her creatinine improved back to baseline. Pt.'s generalized weakness improved with hydration. PT/OT recommended home with assist with home PT/OT. Pt. will follow up with her PCP outpatient. She is discharging in improved and stable condition.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Autonomic nervous system imbalance, Blood pressure orthostatic abnormal, Blood test abnormal, Dyspnoea
Clinical narrative: patient collapsed while on a walk/jog 2 days after secondn dose of covid vaccine. Ended up being transported via ambulance to ER.  Symptoms were short of breath, tachycardia, couldn't move left side of body, could not respond to questions being asked of her although she could hear people and understand. (she told me later that she couldn't move to answer the questions.) Eventually came out of it, ER doc said she had a vasovagal syncope episode and that it was completely normal. The very next day at school, she had another episode and then multiple within the next couple of weeks. 9 months of unexplained symptoms... In May of 2022, after several dr. visits, specialists, etc. it was determined she developed dysautonomia/POTS due to the vaccine.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammatory marker increased, Movement disorder, Postural orthostatic tachycardia syndrome, Syncope, Tachycardia
Clinical narrative: patient collapsed while on a walk/jog 2 days after secondn dose of covid vaccine. Ended up being transported via ambulance to ER.  Symptoms were short of breath, tachycardia, couldn't move left side of body, could not respond to questions being asked of her although she could hear people and understand. (she told me later that she couldn't move to answer the questions.) Eventually came out of it, ER doc said she had a vasovagal syncope episode and that it was completely normal. The very next day at school, she had another episode and then multiple within the next couple of weeks. 9 months of unexplained symptoms... In May of 2022, after several dr. visits, specialists, etc. it was determined she developed dysautonomia/POTS due to the vaccine.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: patient came in to receive their 4th dose which would be the Pfizer bivalent booster.  I MISTAKENLY gave them the new COMIRNATY (Pfizer) monovalent dose.  Upon realization that evening, I called patient to follow up and let them know of the error.  I let them know the guidelines that they do not need to restart the series and advised them to return in 2 months for the bivalent booster.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dizziness, Dyspnoea, Malaise
Clinical narrative: Patient came to the ED with shortness of breath, dizziness, and chills.  Symptoms started after dose of Paxlovid and azithromycin.  Patient was admitted to the hospital with Covid and treated with remdesivir.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arteriovenous malformation, Cerebral haemorrhage, Computerised tomogram head abnormal, Diplopia, Headache
Clinical narrative: On 10/13/2022, about 10:00PM, I got a very bad headache. I went to urgent care Wednesday and Friday. They said it wasn't COVID-19, it was a virus. Then on Saturday, I woke and for about ten minutes I had double vision. I had the same thing on Sunday. On Monday, I called my Primary Care Physician. The nurse called me back early afternoon. She said go to the emergency room. There, they did a CT Scan and said it was a brain bleed. I was hospitalized and in the ICU for five days. Then in January, I had radiological surgery. They determined an Arteriovenous Malformation. I am fine.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Intensive care, Magnetic resonance imaging head abnormal, Radiotherapy to brain, SARS-CoV-2 test negative
Clinical narrative: On 10/13/2022, about 10:00PM, I got a very bad headache. I went to urgent care Wednesday and Friday. They said it wasn't COVID-19, it was a virus. Then on Saturday, I woke and for about ten minutes I had double vision. I had the same thing on Sunday. On Monday, I called my Primary Care Physician. The nurse called me back early afternoon. She said go to the emergency room. There, they did a CT Scan and said it was a brain bleed. I was hospitalized and in the ICU for five days. Then in January, I had radiological surgery. They determined an Arteriovenous Malformation. I am fine.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Anticoagulant therapy, Blood pressure increased, COVID-19, Deep vein thrombosis, Pelvic venous thrombosis
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/3/2023 Discharge Date: 3/6/23  PRESENTING PROBLEM: Acute deep vein thrombosis (DVT) of femoral vein of left lower extremity (HCC) [I82.412] Acute deep vein thrombosis (DVT) of proximal vein of left lower extremity (HCC) [I82.4Y2]   HOSPITAL COURSE: Very pleasant 68-year-old woman with heterozygous factor 5 Leiden, she had COVID 4 weeks ago, went on a 2500mi road trip and returned 2 days ago.  She presented with acute left leg swelling and calf pain found to have a extensive left lower extremity DVT.   She has never had a DVT herself.  She denies any chest pain, palpitations or dyspnea on exertion.  She has never had surgery to the lower extremities or prior vein problems.  She does take an aspirin daily due to her history of heterozygous factor 5 Leiden.  She was on estrogen patch for menopause up until December 2022.  Most of her relatives have had DVTs in the past.   In the emergency department, she was afebrile, heart rate 77, blood pressure 150/93, 100% on room air.  DVT duplex was obtained which showed a extensive left lower extremity DVT extending to the left iliac vein. She will be admitted for IR intervention of extensive DVT.   She underwent mechanical thrombectomy with stent placement with IR during her hospital stay. She was continued with hep gtt surrounding the procedure. She was then started on plavix and Eliquis prior to discharge with plans to continue Eliquis x 1 year and plavix x 6 weeks per recs. She was discharged home in stable conditions with plans to f/u with her PCP to discuss med changes and elevated BP
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Peripheral swelling, Stent placement, Thrombectomy, Ultrasound Doppler
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/3/2023 Discharge Date: 3/6/23  PRESENTING PROBLEM: Acute deep vein thrombosis (DVT) of femoral vein of left lower extremity (HCC) [I82.412] Acute deep vein thrombosis (DVT) of proximal vein of left lower extremity (HCC) [I82.4Y2]   HOSPITAL COURSE: Very pleasant 68-year-old woman with heterozygous factor 5 Leiden, she had COVID 4 weeks ago, went on a 2500mi road trip and returned 2 days ago.  She presented with acute left leg swelling and calf pain found to have a extensive left lower extremity DVT.   She has never had a DVT herself.  She denies any chest pain, palpitations or dyspnea on exertion.  She has never had surgery to the lower extremities or prior vein problems.  She does take an aspirin daily due to her history of heterozygous factor 5 Leiden.  She was on estrogen patch for menopause up until December 2022.  Most of her relatives have had DVTs in the past.   In the emergency department, she was afebrile, heart rate 77, blood pressure 150/93, 100% on room air.  DVT duplex was obtained which showed a extensive left lower extremity DVT extending to the left iliac vein. She will be admitted for IR intervention of extensive DVT.   She underwent mechanical thrombectomy with stent placement with IR during her hospital stay. She was continued with hep gtt surrounding the procedure. She was then started on plavix and Eliquis prior to discharge with plans to continue Eliquis x 1 year and plavix x 6 weeks per recs. She was discharged home in stable conditions with plans to f/u with her PCP to discuss med changes and elevated BP
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Chest X-ray
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 3/3/2023 Discharge Date:  03/06/2023  PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]  HOSPITAL COURSE: Patient did well.  He was weaned off supplemental oxygen during the daytime, ambulating with minimal difficulty.  He was treated with Zosyn initially which was transition to Augmentin to complete a 7 day course for suspected aspiration pneumonia.  He was started on Decadron for COVID-19 pneumonia, switched to prednisone with slow taper for COVID-19 pneumonia.  Patient's weakness improved.  He will continue on a modified diet as before for dysphagia.  He was tolerating his diet while here, all cultures remain negative, inflammatory markers improved.  Patient is stable for discharge.  Recommend he follow up with primary care provider next week, repeat chest x-ray in 4 weeks.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Culture negative, Dysphagia, Gait disturbance, Inflammatory marker test, Medical diet
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 3/3/2023 Discharge Date:  03/06/2023  PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]  HOSPITAL COURSE: Patient did well.  He was weaned off supplemental oxygen during the daytime, ambulating with minimal difficulty.  He was treated with Zosyn initially which was transition to Augmentin to complete a 7 day course for suspected aspiration pneumonia.  He was started on Decadron for COVID-19 pneumonia, switched to prednisone with slow taper for COVID-19 pneumonia.  Patient's weakness improved.  He will continue on a modified diet as before for dysphagia.  He was tolerating his diet while here, all cultures remain negative, inflammatory markers improved.  Patient is stable for discharge.  Recommend he follow up with primary care provider next week, repeat chest x-ray in 4 weeks.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia aspiration
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 3/3/2023 Discharge Date:  03/06/2023  PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]  HOSPITAL COURSE: Patient did well.  He was weaned off supplemental oxygen during the daytime, ambulating with minimal difficulty.  He was treated with Zosyn initially which was transition to Augmentin to complete a 7 day course for suspected aspiration pneumonia.  He was started on Decadron for COVID-19 pneumonia, switched to prednisone with slow taper for COVID-19 pneumonia.  Patient's weakness improved.  He will continue on a modified diet as before for dysphagia.  He was tolerating his diet while here, all cultures remain negative, inflammatory markers improved.  Patient is stable for discharge.  Recommend he follow up with primary care provider next week, repeat chest x-ray in 4 weeks.
Age: 66.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Abdominal pain, COVID-19, Chills, Cough, Hepatic pain
Clinical narrative: I started having symptoms on 01/20/2023 with mild cough, nasal congestion and shivering. I noticed when I coughed, I had pain in my abdominal area. I was having pain in my liver. I seen my provider and prescribed PAXLOVID 5 day supply. Then a week later I had rebound COVID-19. Same symptoms but worst. I did have follow up labs.
Age: 66.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Laboratory test, Malaise, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: I started having symptoms on 01/20/2023 with mild cough, nasal congestion and shivering. I noticed when I coughed, I had pain in my abdominal area. I was having pain in my liver. I seen my provider and prescribed PAXLOVID 5 day supply. Then a week later I had rebound COVID-19. Same symptoms but worst. I did have follow up labs.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin warm, Urticaria
Clinical narrative: I did not have a reaction to the vaccine. In 02/2022 I developed hives on my chest area which was very hot and itchy. It moved to my arm and legs. It lasted about 8 months. I took CLARITIN and ALLEGRA which helped with my symptoms. As of today, I do not have hives and feeling better.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Body temperature increased, COVID-19, Cough, Nasal congestion, Rhinorrhoea
Clinical narrative: I tested positive for COVID-19 on December 18, 2022. I had a mild cough and a temperature that ranged from 99.9-degrees to 101.8-degrees. I had a slightly runny nose and some nasal congestion. He prescribed molnupiravir because I was not a candidate for PAXLOVID. I tested positive for COVID-19 for a full week. On the 9th day, I tested negative for COVID-19.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on December 18, 2022. I had a mild cough and a temperature that ranged from 99.9-degrees to 101.8-degrees. I had a slightly runny nose and some nasal congestion. He prescribed molnupiravir because I was not a candidate for PAXLOVID. I tested positive for COVID-19 for a full week. On the 9th day, I tested negative for COVID-19.
Age: 87.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, COVID-19, Condition aggravated, Cough
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/4/2023 Discharge Date: Mar 7, 2023  PRESENTING PROBLEM: Pulmonary embolism, bilateral [I26.99]   HOSPITAL COURSE: Patient is a 88 year old female with history of breast cancer s/p mastectomy, bilateral PE in 2013 and DVT in 2021 who was admitted 3/4 with bilateral pulmonary emboli and bilateral DVTs.    For several weeks leading up to admission the patient has not felt well and so has not been taking her home medications including Eliquis.  She did have a recent COVID infection at the same time.  She continued to feel ill with shortness of breath, cough, lightheadedness she presented to the emergency department on 03/04.  CT angiogram showed bilateral pulmonary emboli with moderate to large clot burden.  Initially she was at an outside hospital and transferred to Hospital for evaluation for thrombectomy.  Echo was obtained which showed right heart strain.  She underwent thrombectomy and 3/5 with large volume thrombus retrieved on the right and moderate volume retrieved on the left.  She tolerated the procedure well and she was transitioned from heparin drip to Eliquis on 03/06.  She did have bilateral DVTs in the right common femoral, right gastrocnemius, right popliteal and an occluded stent in the left femoral veins.  She was asymptomatic from this and she had duplicated femoral vein so did not need to treat the clock and the stent.  She was encouraged to wear compression stockings.   Patient continued to require supplemental oxygen of about 2 L at all times.  She was evaluated by Pulmonary Rehab who recommended the oxygen at all times of 2 L. she was discharged in stable condition on 03/07 to home with home nursing and physical therapy.    Patient to continue with Eliquis 5mg twice daily.  She will need to follow up with pulmonology in about 2-3 months for repeat echo and CT scan to assess clots.
Age: 87.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Deep vein thrombosis, Device occlusion, Dizziness, Dyspnoea, Echocardiogram abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/4/2023 Discharge Date: Mar 7, 2023  PRESENTING PROBLEM: Pulmonary embolism, bilateral [I26.99]   HOSPITAL COURSE: Patient is a 88 year old female with history of breast cancer s/p mastectomy, bilateral PE in 2013 and DVT in 2021 who was admitted 3/4 with bilateral pulmonary emboli and bilateral DVTs.    For several weeks leading up to admission the patient has not felt well and so has not been taking her home medications including Eliquis.  She did have a recent COVID infection at the same time.  She continued to feel ill with shortness of breath, cough, lightheadedness she presented to the emergency department on 03/04.  CT angiogram showed bilateral pulmonary emboli with moderate to large clot burden.  Initially she was at an outside hospital and transferred to Hospital for evaluation for thrombectomy.  Echo was obtained which showed right heart strain.  She underwent thrombectomy and 3/5 with large volume thrombus retrieved on the right and moderate volume retrieved on the left.  She tolerated the procedure well and she was transitioned from heparin drip to Eliquis on 03/06.  She did have bilateral DVTs in the right common femoral, right gastrocnemius, right popliteal and an occluded stent in the left femoral veins.  She was asymptomatic from this and she had duplicated femoral vein so did not need to treat the clock and the stent.  She was encouraged to wear compression stockings.   Patient continued to require supplemental oxygen of about 2 L at all times.  She was evaluated by Pulmonary Rehab who recommended the oxygen at all times of 2 L. she was discharged in stable condition on 03/07 to home with home nursing and physical therapy.    Patient to continue with Eliquis 5mg twice daily.  She will need to follow up with pulmonology in about 2-3 months for repeat echo and CT scan to assess clots.
Age: 87.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Malaise, Pulmonary embolism, Pulmonary thrombosis, Right ventricular dysfunction, Thrombectomy
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/4/2023 Discharge Date: Mar 7, 2023  PRESENTING PROBLEM: Pulmonary embolism, bilateral [I26.99]   HOSPITAL COURSE: Patient is a 88 year old female with history of breast cancer s/p mastectomy, bilateral PE in 2013 and DVT in 2021 who was admitted 3/4 with bilateral pulmonary emboli and bilateral DVTs.    For several weeks leading up to admission the patient has not felt well and so has not been taking her home medications including Eliquis.  She did have a recent COVID infection at the same time.  She continued to feel ill with shortness of breath, cough, lightheadedness she presented to the emergency department on 03/04.  CT angiogram showed bilateral pulmonary emboli with moderate to large clot burden.  Initially she was at an outside hospital and transferred to Hospital for evaluation for thrombectomy.  Echo was obtained which showed right heart strain.  She underwent thrombectomy and 3/5 with large volume thrombus retrieved on the right and moderate volume retrieved on the left.  She tolerated the procedure well and she was transitioned from heparin drip to Eliquis on 03/06.  She did have bilateral DVTs in the right common femoral, right gastrocnemius, right popliteal and an occluded stent in the left femoral veins.  She was asymptomatic from this and she had duplicated femoral vein so did not need to treat the clock and the stent.  She was encouraged to wear compression stockings.   Patient continued to require supplemental oxygen of about 2 L at all times.  She was evaluated by Pulmonary Rehab who recommended the oxygen at all times of 2 L. she was discharged in stable condition on 03/07 to home with home nursing and physical therapy.    Patient to continue with Eliquis 5mg twice daily.  She will need to follow up with pulmonology in about 2-3 months for repeat echo and CT scan to assess clots.
Age: 87.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Treatment noncompliance
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/4/2023 Discharge Date: Mar 7, 2023  PRESENTING PROBLEM: Pulmonary embolism, bilateral [I26.99]   HOSPITAL COURSE: Patient is a 88 year old female with history of breast cancer s/p mastectomy, bilateral PE in 2013 and DVT in 2021 who was admitted 3/4 with bilateral pulmonary emboli and bilateral DVTs.    For several weeks leading up to admission the patient has not felt well and so has not been taking her home medications including Eliquis.  She did have a recent COVID infection at the same time.  She continued to feel ill with shortness of breath, cough, lightheadedness she presented to the emergency department on 03/04.  CT angiogram showed bilateral pulmonary emboli with moderate to large clot burden.  Initially she was at an outside hospital and transferred to Hospital for evaluation for thrombectomy.  Echo was obtained which showed right heart strain.  She underwent thrombectomy and 3/5 with large volume thrombus retrieved on the right and moderate volume retrieved on the left.  She tolerated the procedure well and she was transitioned from heparin drip to Eliquis on 03/06.  She did have bilateral DVTs in the right common femoral, right gastrocnemius, right popliteal and an occluded stent in the left femoral veins.  She was asymptomatic from this and she had duplicated femoral vein so did not need to treat the clock and the stent.  She was encouraged to wear compression stockings.   Patient continued to require supplemental oxygen of about 2 L at all times.  She was evaluated by Pulmonary Rehab who recommended the oxygen at all times of 2 L. she was discharged in stable condition on 03/07 to home with home nursing and physical therapy.    Patient to continue with Eliquis 5mg twice daily.  She will need to follow up with pulmonology in about 2-3 months for repeat echo and CT scan to assess clots.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anaemia, Arrhythmia, Fatigue, Headache, Hypertension
Clinical narrative: The very next day, I started having a terrible headache, and high blood pressure. It was almost as if I was having a TA. I could barely speak. I couldn?t form my words right. I was fatigued terrible and developed arrythmia.  I rested and called my PCP. I did intake of fluids. I have been extremely anemic as well. I have been getting Iron Infusions IVs.  All of this a continuance of what I reported on the first shot.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Mineral supplementation, Speech disorder
Clinical narrative: The very next day, I started having a terrible headache, and high blood pressure. It was almost as if I was having a TA. I could barely speak. I couldn?t form my words right. I was fatigued terrible and developed arrythmia.  I rested and called my PCP. I did intake of fluids. I have been extremely anemic as well. I have been getting Iron Infusions IVs.  All of this a continuance of what I reported on the first shot.
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Client was given Pfizer (6 mo-4year) Bivalent Booster after having 3 primary series COVID vaccinations -- No adverse effects after vaccination
Age: 80.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Asthenia, COVID-19, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: Primary Care Provider: MD Admission Date: 3/2/2023 Discharge Date: Mar 6, 2023  PRESENTING PROBLEM: COVID-19   HOSPITAL COURSE: 80 y.o. male with a PMH of OSA C-pap, Obesity, Essential Hypertension, GERD, T2 DM, and Migraines, who presents today with severe generalized weakness. That started 2 days prior to arrival. Patient admitted for further management of weakness associated with COVID. In the ER the patient was febrile with a temp 39.1 C.  COVID positive. Patient without respiratory distress saturating well on RA, and thus did not warrant treatment for COVID, was treated with supportive care. PT/OT evaluated patient and recommended SAR initially but was able to progress to home with home health care. Patient medically stable for discharge home 3/6. Also enrolled in transition to home program for further monitoring once discharged
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: High blood pressure
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered, Medication error
Clinical narrative: Medication error; second dose of bivalent vaccine administered.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Delivered Pfizer-Biotech bivalent omicron vaccines in December. Expiration on bottle was 09/2022. Vaccines best use by date was February 15, 2022 according to the Department. Has the expiration date as 8/2023 so there was confusion of when the doses expired.
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Immunisation reaction, Injection site pain, Joint range of motion decreased, Pain
Clinical narrative: Per patient report, "Immediately upon receiving the vaccine I shrieked because I felt the shot shoot down my arm into my fingertips. I?m not sure if you were at the conference, but I am one of the co-chairs of the conference and I was given my shot when all the attendees were in the conference hall, so there were just the two nurses and a couple of us who were doing registration, etc. out in the lobby. We all laughed and joked about how we don?t usually hurt our own and just kind of went along with our day.     In any event, I am still experiencing extreme upper left arm pain that radiates down my left elbow, forearm and into my fingertips. I have extreme limited range of motion of my shoulder and was diagnosed with frozen shoulder due to vaccine administration. I am being treated for this and have started to see improvement."
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity, Periarthritis, Screaming, Shoulder injury related to vaccine administration
Clinical narrative: Per patient report, "Immediately upon receiving the vaccine I shrieked because I felt the shot shoot down my arm into my fingertips. I?m not sure if you were at the conference, but I am one of the co-chairs of the conference and I was given my shot when all the attendees were in the conference hall, so there were just the two nurses and a couple of us who were doing registration, etc. out in the lobby. We all laughed and joked about how we don?t usually hurt our own and just kind of went along with our day.     In any event, I am still experiencing extreme upper left arm pain that radiates down my left elbow, forearm and into my fingertips. I have extreme limited range of motion of my shoulder and was diagnosed with frozen shoulder due to vaccine administration. I am being treated for this and have started to see improvement."
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood sodium decreased, COVID-19, Condition aggravated, Hyponatraemia, Laboratory test abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/3/2023 Discharge Date: Mar 5, 2023   PRESENTING PROBLEM: Hyponatremia [E87.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Patient is a 73 y.o. male with past medical history significant for CAD with stents, DLD, HTN, PMR, kidney stones, possible RA, DM II, chronic neck pain and cervical spinal fusion who was recently found to have COVID-19. He scheduled outpatient remdesivir infusions and presented to his appointment on 3/3. Routine lab work before the infusion found acute hyponatremia to 120 and he was instructed to go to the ER for further evaluation.    He had been trying to keep up hydration with water. He was given IV fluids in the ER and admitted to medicine for further management. He was continued on fluid resuscitation with close monitoring of sodium to prevent overcorrection. His chlorthalidone was stopped. He had slow and appropriate increase in his sodium levels up to previous baseline of 130.    For his COVID he was started on remdesivir for 3 days. On 3/5 his COVID was improving. He was never hypoxic. His sodium returned to his baseline. After shared decision making he was discharged in stable condition. He will f/u with his PCP.
Age: 91.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Anticoagulation drug level below therapeutic, Blood pressure increased, COVID-19, Chest X-ray normal, Dyspnoea
Clinical narrative: Discharge Provider: FNP Primary Care Provider at Discharge: FNP  Admission Date: 3/1/2023 Discharge Date: 03/02/2023  PRESENTING PROBLEM: COVID-19 virus infection   HOSPITAL COURSE: Patient is a 92 year old male with history of chronic atrial fibrillation on oral anticoagulation with warfarin who presented to the ED with complaints of sore throat for one day. In the ED they ambulated him but his oxygen saturations remained 90% but he appeared to have significant work of breathing. Labs revealed that he was positive for COVID 19. Chest xray was done which was nonconcerning. Due to his shortness of breath with walking the ED provider requested the hospiaist service to consult. Patient endorses a long standing history of shortness of breath with activity and per recent office visit it also makes note of this. Patient denies any worsening of his shortness of breath from baseline. He was monitored overnight and his oxygen saturations remained normal on room air, and he was not in any distress. His blood pressure was elevated and recommended that this be followed up outpatient. We did continue his coumadin and this will need to be followed up as on day of discharge his INR was slightly subtherapeutic.   Patient is being discharged in stable condition and was agreeable with discharge plans.
Age: 91.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Dyspnoea exertional, Laboratory test abnormal, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: FNP Primary Care Provider at Discharge: FNP  Admission Date: 3/1/2023 Discharge Date: 03/02/2023  PRESENTING PROBLEM: COVID-19 virus infection   HOSPITAL COURSE: Patient is a 92 year old male with history of chronic atrial fibrillation on oral anticoagulation with warfarin who presented to the ED with complaints of sore throat for one day. In the ED they ambulated him but his oxygen saturations remained 90% but he appeared to have significant work of breathing. Labs revealed that he was positive for COVID 19. Chest xray was done which was nonconcerning. Due to his shortness of breath with walking the ED provider requested the hospiaist service to consult. Patient endorses a long standing history of shortness of breath with activity and per recent office visit it also makes note of this. Patient denies any worsening of his shortness of breath from baseline. He was monitored overnight and his oxygen saturations remained normal on room air, and he was not in any distress. His blood pressure was elevated and recommended that this be followed up outpatient. We did continue his coumadin and this will need to be followed up as on day of discharge his INR was slightly subtherapeutic.   Patient is being discharged in stable condition and was agreeable with discharge plans.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Intervertebral disc protrusion, Loss of personal independence in daily activities, Magnetic resonance imaging abnormal, Muscle tightness
Clinical narrative: My adverse event started on 09/06/2022 not sure about the time exactly. It was between 4th and 5th dose. I had some kind of virus not really sure. I had fever and started vomiting. I took Aleve for fever but I didn't see any doctor for it.  My back felt tight after 4th dose. After the 5th dose the tightness along with pain. I couldn't sit for long time. I was experiencing Sciatica pain in my back. I went to see my doctor on 09/13/2022. They gave me an Anti-Inflammatory shot on my back  and Cyclobenzaprine ( muscles relaxer). They did an  X-Ray  which was abnormal and they thought I had Arthritis. I  called and requested an MRI which was done on the same month where they ruled out  I had Herniated disc.  I am  recovering as of now but I have to be careful of what I do in my daily life. I have to be careful of bending or trying to carry heavy things since I still have the back pain.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Sciatica, Viral infection, Vomiting, X-ray abnormal
Clinical narrative: My adverse event started on 09/06/2022 not sure about the time exactly. It was between 4th and 5th dose. I had some kind of virus not really sure. I had fever and started vomiting. I took Aleve for fever but I didn't see any doctor for it.  My back felt tight after 4th dose. After the 5th dose the tightness along with pain. I couldn't sit for long time. I was experiencing Sciatica pain in my back. I went to see my doctor on 09/13/2022. They gave me an Anti-Inflammatory shot on my back  and Cyclobenzaprine ( muscles relaxer). They did an  X-Ray  which was abnormal and they thought I had Arthritis. I  called and requested an MRI which was done on the same month where they ruled out  I had Herniated disc.  I am  recovering as of now but I have to be careful of what I do in my daily life. I have to be careful of bending or trying to carry heavy things since I still have the back pain.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: I tested positive for COVID-19 on December 25, 2022 I experienced congestion, fatigue, a cough, a sore throat.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on December 25, 2022 I experienced congestion, fatigue, a cough, a sore throat.
Age: 0.67
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Bivalent vaccine used for dose 2 in primary series.
Age: 26.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product administration error
Clinical narrative: Administration error. Vaccines delivered to Family Medicine 12/2022. Vaccines with expiration date on vial says 09/2022.  Expiration date in Immunization Information System states expiration of 08/2023. Patient given vaccine when vaccines were supposed to be thrown out at 10 week from arrival date. Vaccine is supposed to be viable even though given after Public Health expiration date.  NO adverse event occurred.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arteriosclerosis, Blood pressure increased, Blood test, Cardiac stress test, Chest X-ray abnormal
Clinical narrative: I woke up around 3AM on 02/24/2023 with a heavy pressure in my left arm and really high blood pressure. The blood pressure got up to 169/102. At that point, I went to the ER and they did all the tests for heart attack. There was something on the EKG that made them uncomfortable dismissing me. My blood pressure was still high, so they gave me Diltiazem and they ran a chemical stress test. That came out okay and I was sent home. They gave me a prescription for the Diltiazem and I started that prescription. That's gotten my blood pressure under control for the time being. I'm taking that on top of the Metoprolol that I'm already taking. For the arm pain, they noted that it could be coincidental.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Electrocardiogram abnormal, Laboratory test, Limb discomfort, Myocardial necrosis marker, Sleep disorder
Clinical narrative: I woke up around 3AM on 02/24/2023 with a heavy pressure in my left arm and really high blood pressure. The blood pressure got up to 169/102. At that point, I went to the ER and they did all the tests for heart attack. There was something on the EKG that made them uncomfortable dismissing me. My blood pressure was still high, so they gave me Diltiazem and they ran a chemical stress test. That came out okay and I was sent home. They gave me a prescription for the Diltiazem and I started that prescription. That's gotten my blood pressure under control for the time being. I'm taking that on top of the Metoprolol that I'm already taking. For the arm pain, they noted that it could be coincidental.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Pain at injection site, itchiness at injection site, redness at injection site on left arm.   Fully resolved of issues.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Blood lactic acid normal, Blood potassium decreased, COVID-19, Chronic obstructive pulmonary disease
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/1/2023 Discharge Date: 3/5/2023   Clinical Narrative: Patient was admitted for acute chronic obstructive pulmonary disease exacerbation and COVID-19, however his cough has much improved, he has remained on room since the day after he was admitted and saturating in the mid 90s, he denies any chest pain.  He was started on IV remdesivir on admission and has completed 4 days.  He remains afebrile with no shortness of breath no chest pain.  Leukocytosis today is felt to be reactive from steroids would repeated procalcitonin lactic acid today which but normal.  Physician at the extended care facility to repeat complete blood count within 1 week.  Examination reveals no wheeze, since he is on room air with no shortness of breath we may discontinue steroids today on discharge since he has had a total of 4 days Decadron He was evaluated by General surgery during this admission to assist with these bilateral Unna boot He was evaluated by PT/OT for history of falls and will be transferred to extended care facility for rehabilitation Patient is on Coumadin for anticoagulation and he was subtherapeutic on admission, with subsequently bridged with Lovenox, his INR however today is 2.7 so we will discontinue Lovenox bridge.  Potassium was 3.2 this morning and he received a total of 40 mEq of potassium replacement   Please see the following problem-list oriented Hospital Course below:   No new Assessment & Plan notes have been filed under this hospital service since the last note was generated. Service: Hospitalist
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Electrolyte substitution therapy, International normalised ratio increased, Leukocytosis
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/1/2023 Discharge Date: 3/5/2023   Clinical Narrative: Patient was admitted for acute chronic obstructive pulmonary disease exacerbation and COVID-19, however his cough has much improved, he has remained on room since the day after he was admitted and saturating in the mid 90s, he denies any chest pain.  He was started on IV remdesivir on admission and has completed 4 days.  He remains afebrile with no shortness of breath no chest pain.  Leukocytosis today is felt to be reactive from steroids would repeated procalcitonin lactic acid today which but normal.  Physician at the extended care facility to repeat complete blood count within 1 week.  Examination reveals no wheeze, since he is on room air with no shortness of breath we may discontinue steroids today on discharge since he has had a total of 4 days Decadron He was evaluated by General surgery during this admission to assist with these bilateral Unna boot He was evaluated by PT/OT for history of falls and will be transferred to extended care facility for rehabilitation Patient is on Coumadin for anticoagulation and he was subtherapeutic on admission, with subsequently bridged with Lovenox, his INR however today is 2.7 so we will discontinue Lovenox bridge.  Potassium was 3.2 this morning and he received a total of 40 mEq of potassium replacement   Please see the following problem-list oriented Hospital Course below:   No new Assessment & Plan notes have been filed under this hospital service since the last note was generated. Service: Hospitalist